Notable healthcare headlines for the week: UnitedHealth, Molina Healthcare, and Novo Nordisk in focus
Wall Street's major averages struggled to hold onto gains on Friday, with both the S&P 500 and the Nasdaq Composite...
Tag: LLY
Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
A new Reuters report, based on data from healthcare research firm 3 Axis Advisors, names Pfizer (PFE) and GSK (GSK) among...
Vanda surges on FDA approval of Lilly-partnered motion sickness therapy
Vanda Pharmaceuticals (VNDA) added ~21% in the premarket on Wednesday after the U.S. FDA approved its motion sickness...
4 stocks to watch on Tuesday: META, LLY, BA, TAK
Stock index futures were higher ahead of the open, a day after a tech sell-off led to a red day on Wall Street. Here are...
Eli Lilly, Novo waging price wars as obesity drug market heats up in China
Eli Lilly (LLY) and Novo Nordisk (NVO) are slashing prices of their GLP-1 products in China as the rivalry in the booming...
CMS unveils payment model to boost GLP-1 access for Medicare Part D, Medicaid
CMS has unveiled a voluntary payment model for for Medicare Part D plans and state Medicaid agencies to lower the costs of...
GLP-1 weight loss meds lead to changes in consumer food demand – study
Weight loss isn't the only change Individuals who are taking a GLP-1 weight loss medicine are seeing. They also tend to...
Here are the most and least likely M&A targets in biotech, according to Truist
French biotech (ABVX) has emerged as the most likely acquisition target among biotechs in 2026, significantly outpacing...
Novo’s Wegovy pill could be a game-changer, but Lilly is not far behind
Novo Nordisk (NVO) shares rallied on Tuesday after the U.S. FDA approved its Wegovy pill for weight management, marking a...
Lilly-backed radiophama startup Atkis seeks U.S. IPO
Aktis Oncology (AKTS), a radiopharmaceutical drug developer backed by pharma giants such as Eli Lilly (LLY), has filed its...